It's Now Allowed To Test The Coronavirus Vaccine On Human In Germany
The German Federal Institute of vaccines and biomedical drugs PEI (Paul Ehrlich Institute) has issued the first permit for clinical testing of the vaccine against the coronavirus COVID-19, the press service of the institution said.
"The permit is the result of a careful assessment of the potential risk and benefit of the candidate for testing," the press service said.
The test vaccine was produced by a company from the city of Mainz, Biontech, and now it can test it on volunteers.
"Testing the "vaccine candidate" in humans is an important milestone on the way to developing a safe and effective drug against COVID-19 for the German population and beyond," the Institute points out.
Biotech has developed an RNA vaccine that contains genetic information in the form of ribonucleic acid. "As part of the first part of the permitted clinical testing, 200 healthy test participants aged 18 to 55 years will be vaccinated," the press service of the scientific institution reports.